Sarepta治疗 SRPT 深 沪
已收盘 12-19 16:00:00 美东时间
21.04
+0.700
+3.44%
华盛通- 最 高23.00
- 今 开20.33
- 成交量 226.62万股
- 最 低 18.73
- 昨 收 20.34
- 总市值 18.41亿
- 52周最高 129.84
- 市盈率 静 --
- 换手率 2.59%
- 52周最低 10.415
- 委 比 -64.52%
- 总股本 8750.10万
- 历史最高 181.83
- 量 比 0.79
- 振 幅 20.99%
- 历史最低 1.10
- 每 手 1
- 风险率 38.50%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Dyne's Duchenne Drug Shows Strong Muscle And Function Improvements
Dyne Therapeutics reported positive results from Phase 1/2 DELIVER trial for z-rostudirsen in DMD amenable to exon 51 skipping.
12-09 02:37
Silver Soars Past $58, Bitcoin-Strategy Bloodbath Deepens: What's Moving Markets Monday?
Wall Street kicked off December with stocks slightly easing after a strong late-November rally, as rising global bond yields and sharp moves in commodities and crypto set a more cautious tone for equity traders.
12-02 02:25
Arrowhead Pharmaceuticals Earns $200M Milestone Payment From Sarepta Therapeutics
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it has earned a $200 million milestone payment from Sarepta Therapeutics (NASDAQ:SRPT). The milestone was earned when Arrowhead achieved the second
11-24 20:31
Sarepta Shares Jump After FDA Approves Updated Elevidys Label
Sarepta Therapeutics shares jumped after the FDA issued a new boxed warning for Elevidys.
11-15 06:48
Sarepta Stock Dumps: Pharma Bro Martin Shkreli Still Likes It
Enough though Sarepta shares are crashing, "Pharma Bro" Martin Shkreli says he still likes the stock.
11-05 01:11
Market-Moving News for November 4th
PRLD: 70% | Prelude Therapeutics Signs Agreement For Incyte To Acquire JAK2V617F JH2 Inhibitor Program In Development For Patients With Myeloproliferative Neoplasms NSP: -32% | Insperity shares are trading
11-04 20:24
Top Stocks With Earnings This Week: Joby, IonQ, AMD and More
Retail investors are preparing for another busy week of earnings season with more than 1,600 companies set to report through Friday.
11-03 22:14
Earnings Scheduled For November 3, 2025
Companies Reporting Before The Bell • CNA Financial (NYSE:CNA) is expected to r...
11-03 19:11
礼来动物保健将加入标普中型股400指数
美东时间周三早盘，礼来动物保健公司（ELAN）股价上涨3.5%。该公司将加入标普中型股400指数，取代将转入标普小型股600指数的Sarepta Therapeutics公司（SRPT）。 此次调整是在伯克希尔山银行收购布鲁克林银行之后进行的，后者将在更名后继续留在标普小型股600指数中。 海量资讯、精准解读，尽在新浪财经APP 责任编辑：张俊 SF065
08-27 22:14
Sarepta拒绝FDA撤回药物的要求，其股价持续下滑
核心要点 索雷帕塔治疗公司（Sarepta Therapeutics）拒绝了美国食品药品监督管理局（FDA）关于停止其肌肉萎缩症药物发货的要求。 美国食品药品监督管理局之所以提出这一要求，是因为在一项 1 期研究中，第三名接受类似治疗的患者死亡。 这家生物制药公司的股价周一下滑，延续了上周的跌势。 索雷帕塔治疗公司（SRPT）的股价周一继续下滑，原因是这家生物制药公司拒绝了美国食品药品监督管理局要求其停止分发用于治疗肌肉萎缩症的药物 Elevidys 的请求。 在一项 1 期研究中，第三名患有某种肌肉萎缩症、接受与 Elevidys 类似的基因治疗的患者因肝功能衰竭死亡（可能与该药...
07-21 23:09
